At meeting held on 03 December 2019
The Board of Indrayani Biotech at its meeting held on 03 December 2019 has discussed about the proposed Scheme of Arrangement of Indrayani Biotech (transferee company) with Helios Solutions (transferor company 1) and A-diet Express Hospitality (transferor company 2).The company had filed necessary document related to Regulation 37 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, with BSE Limited. On 20 November 2019, the Company received an observation letter from BSE Limited stating no adverse observation for the proposed Scheme of Arrangement. In continuation to that, the Board of Directors decided to file necessary Application with National Company Law Tribunal (NCLT), Chennai. The draft Application has been presented to the Board and the same has been approved.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app